Briefing Detail Page
Health Legislation 2007-2008: What's Possible?
Wednesday, December 13, 2006
Suddenly, Capitol Hill is talking about health issues again. Incoming House Speaker Nancy Pelosi promises that Democrats will roll back the prohibition against the federal government negotiating drug prices on behalf of Medicare beneficiaries. (A Kaiser Family Foundation poll released today found broad bipartisan support for this idea.) Incoming Senate Majority Leader Harry Reid says one of his three top priorities will be more funding for stem cell research. Others want to revisit the importation of prescription drugs from Canada. Additionally, the 110th Congress will consider whether to continue the State Children’s Health Insurance Program in its present form.
The election results, and the launch of the 2008 presidential season, mean a wealth of story ideas for reporters in all media. For instance: Who will be the key players in health care on the Hill for the next two years? Given the election outcome, will we see a dramatic new emphasis on health issues, such as a federal mandate that everyone in the U.S. must have health coverage (a la Massachusetts)? Or should we expect more modest steps toward reform? What’s in store for prescription drug reimportation and stem cell research? What about efforts to help small businesses provide health coverage to their employees? How important will health issues be in the 2008 presidential race?
To help address these and related questions, the Alliance for Health Reform and the Robert Wood Johnson Foundation sponsored a December 13 luncheon briefing for reporters and others in the media. Panelists were Hill insiders well versed in getting health legislation done: Bridgett Taylor, Democratic staff of the House Energy and Commerce Committee; Mark Hayes, Republican health policy director for the Senate Finance Committee; and Kate Leone, health policy advisor to Sen. Reid. Ed Howard, executive vice president of the Alliance, moderated the discussion.
Bridgett Taylor, House Energy and Commerce Committee, Speaker
Kate Leone, Office of Senator Harry Reid, Speaker
Mark Hayes, Senate Finance Committee, Speaker
|Transcript, Event Summary and/or Webcast and Podcast|
Transcript: Transcript: Health Legislation 2007-2008: What's Possible? (Adobe Acrobat PDF), 12/13/2006
Full Webcast/Podcast: Webcast: Health Legislation 2007-2008: What's Possible?
|The transcript, full webcast and podcast for this briefing are provided by Kaiser Family Foundation.
Congress Partially Fills CHIP Shortfall (Word Document), Families USA, 12/11/2006
Michael Enzi on Health Care (Word Document), , 11/1/2006
Chuck Grassley on Health Care (Word Document), , 11/1/2006
|Offsite Materials (briefing documents saved on other websites)|
US Health Benefit Cost Increase Level Off at 6.1% in 2006, Mercer Human Resource Consulting, 11/20/2006
Medicare As Drug Discounter? It's tricky issue: Dem's Push Faces Plenty of Obstacles, Detroit Free Press, 11/19/2006
2006 Health Confidence Survey: Dissatisfaction With Health Care System Doubles Since 1998, EBRI, 11/1/2006
Problems and Priorities, ABC News/ Washington Post Poll, 11/4/2006
New Analysis Underscores Legality of Collecting Patient Race and Ethnicity Data to Improve Heal, Robert Wood Johnson Foundation, 6/22/2006
As Drug Prices Climb, Democrats Find Fault With Medicare Plan, The New York Times, 11/6/2006
FDA plans tougher review of devices: Electronic reports part of program, The Boston Globe, 11/10/2006
With Dems in control: Gridlock or Change, USA Today, 11/9/2006
Medicare, The Washington Post, 11/19/2006
Issues Front and Center: Big Ideas for Democrats: Health Care, Energy and Economic Inequality, The Washington Post, 11/17/2006
Shake-Up in Congress: Johnson, Grassley pass lead roles in Stark, Baucus, Modern Healthcare , 11/13/2006
Insurers Propose to Close Gap, Los Angeles Times, 11/14/2006
Press Release: Former Senator John Breaux Expands Ceasefire on Health are Campaign With Former , Yahoo Finance, 11/16/2006
Democratic Leaders Eye FDA Reforms, The Executive, 11/16/2006
Democratic Lawmakers to Focus on Medicare Changes in 2007, Kaiser Family Foundation, 11/20/2006
Pelosi - One the Issues - Healthcare, Pelosi Official Web sight, 11/1/2006
Health Poll Report Survey: Voters on Health Care and the 2006 Elections, Kaiser Family Foundation, 11/1/2006
Health Poll Report Survey: Voters on Health Care and the 2006 Elections Full Report (Adobe Acrobat PDF),Kaiser Family Foundation, 10/1/2006
Barton Seeks Medicare Physician Payments Fix This Year: Opening Statement of Energy and Com..., Committee on Energy and Commerce, 11/1/2006
House Democrats Likely To Focuss on Medicare HMO Payments, Kaiser Family Foundation, 11/11/2006
Sen. Kennedy Outlines Goals for Senate HELP Committee, Including Universal Coverage for All ..., Kaiser Family Foundation, 11/17/2006
Press Release: Grassley Introduces Bill to Help States Fund Health Care for Low-Income Children, United States Senator Chuck Grassley, 9/28/2006
Clinton- Issues- Health, New York Senator: Hilary Rodham Clinton, 11/1/2006
McCain - Issues - Healthcare, U.S. Senator John McCain, 11/1/2006
Health CAre for Everyone? We've found a Way, Opinion Journal from Wall Street Journal Editorial Page, 9/11/2006
Associated Press: Former Sen. Edwards says Democrats need to show 'backbone', John Edward's One America Committee, 9/11/2006
Senator - Dodd - Issues Prescription Drugs, U.S. Senator Christopher Dodd, 11/1/2006
Senator Bayh - Issues -Healthcare, Senator Evan Bayh, 11/1/2006
Senator Biden - Issues - Healthcare, Senator Joe Biden, 11/1/2006
Senator Obama - Issues - Healthcare, Senator Barack Obama, 11/1/2006
Ex-Bush Aide to Explore Presidential Run, Associated Press, 11/16/2006
Harry Reid - Issues - Healthcare, Senator Harry Reid, 11/1/2006
Health Insurance, Senator Dick Durbin, 11/1/2006
Health Care - Current and Upcoming Health Care Issues, Senator Max Baucus, 11/1/2006
Sen. Baucus to Tackle Health Care Costs, Forbes.com, 11/16/2006
Health Care and the New Congress, Galen Report by the Galen Institute, 11/16/2006
New Congress Unlikely To Address Issue of Uninsured, Opinion Piece Says, Medical News Today, 11/13/2006
Drug IndustryIs Defensive As Power Shifts, The New York Times, 11/24/2006
Success of Drug Plan Challenges Democrats, Washington Post, 11/26/2006
On the Comeback Trail, The Robert Wood Johnson Foundation, 10/30/2006
US Election: Implications of Democratic Control for Healthcare, Goldman Sachs, 11/1/2006
Healthcare Industrie Still Amongst Most Popular Targets for More Regulation but Support for..., The Harris Poll People - Healthcare News, 11/14/2006
Health's Ailment; A new Congress May Patch Up A Few Problems, But Don't Expect a Cure, U.S. News & World Report, 11/20/2006
Mark Hayes, health policy director of the Senate Finance Committee -- speaker at the December 13th press only briefing cosponsored by the Robert Wood Johnson Foundation.
Kate Leone, health counsel to Senator Harry Reid -- speaker at the December 13th press only briefing cosponsored by the Robert Wood Johnson Foundation.
Bridgett Taylor, Democratic staff of the House Energy and Commerce Committee -- speaker at the December 13th press only briefing cosponsored by the Robert Wood Johnson Foundation.
Toolkit on Connection Between Health and Housing
A new Alliance toolkit, “The Connection between Health and Housing: The Evidence and Policy Landscape,” provides a detailed look into federal, state and local initiatives, as well as cost implications for health and housing programs.
Attempts to tie health and housing policy are gaining momentum, amid evidence that housing, a social determinant of health, is an important factor in the health status of various populations. More than 610,000 people experience homelessness in the U.S., and over 250,000 individuals within that population have a severe mental illness or a chronic substance use disorder, according to the Department of Housing and Urban Development.
Toolkit on Biosimilars
The Alliance for Health Reform has released a new toolkit, “Biosimilars: Unpacking Complex Issues.”
The Affordable Care Act created an expedited licensure pathway for biosimilars, and, in March 2015, the U.S. approved the first biosimilar, leaving policy makers, regulators, providers and stakeholders to grapple with regulatory and financial questions.
Biosimilars are similar – but not identical – to biologic drugs, and cost less. Unlike traditional pharmaceuticals, biologic drugs are derived from living organisms and tissues, making them more complex and expensive to produce.